Epidemiology & Risk Factors

  • Idiopathic, progressive fibroinflammatory obliteration of the extrahepatic biliary tree.
  • Onset: Neonates (typically presenting at 2–8 weeks of life).
  • Epidemiology: Most common indication for pediatric liver transplantation.

Clinical Features

  • Healthy at birth with normal birth weight.
  • Progressive jaundice appearing within the first 2–8 weeks.
  • Acholic (pale/clay-colored) stools due to the absence of conjugated bilirubin in the gut.
  • Dark (tea-colored) urine due to renal excretion of water-soluble conjugated bilirubin.
  • Hepatomegaly, firm liver on palpation.
  • Splenomegaly (late sign indicating portal HTN).
  • FTT if diagnosis or treatment is delayed.

Diagnosis

  • Initial Labs: ↑ Direct (conjugated) bilirubin (defined as > 1.0 mg/dL if total < 5.0, or > 20% of total), ↑ GGT, ↑ ALP.
  • Initial Imaging: RUQ US shows absent or small/hypoplastic gallbladder, “triangular cord sign” (fibrous cone of echogenic tissue at the porta hepatis).
  • Screening/Next step: HIDA scan (hepatobiliary scintigraphy) showing normal liver uptake of tracer but failure of excretion into the duodenum after 24 hours (often pre-treated with phenobarbital to stimulate bile secretion).
  • Biopsy: Percutaneous liver biopsy shows bile duct proliferation, portal tract fibrosis, and bile plugs.
  • Confirmatory/Gold Standard: Intraoperative cholangiogram (IOC) demonstrating a non-patent extrahepatic biliary tree.

Differential Diagnostics

  • Breast Milk Jaundice: Differentiated by unconjugated (indirect) hyperbilirubinemia, normal-colored stools, and onset after the first week of life.
  • Neonatal Hepatitis: Differentiated by a patent biliary tree on HIDA scan and a liver biopsy showing giant cell transformation rather than ductal proliferation.
  • Choledochal Cyst: Differentiated by RUQ US showing cystic dilation of the biliary tree.
  • Galactosemia: Differentiated by systemic symptoms (vomiting, cataracts, hypoglycemia, hypotonia) and (+) urine reducing substances.
  • Alagille Syndrome: Differentiated by syndromic features (butterfly vertebrae, peripheral pulmonic stenosis, triangular facies) and bile duct paucity on liver biopsy.

Management

  • First-line (Surgical): Kasai procedure (hepatoportoenterostomy) to restore biliary drainage.
    • Must be performed early (ideally < 8 weeks of age) to prevent progressive liver damage.
  • Supportive:
    • MCT-rich formulas (bypasses lymphatic/biliary absorption barriers).
    • Fat-soluble vitamin supplementation (A, D, E, K).
    • Ursodeoxycholic acid to promote bile flow.
  • Definitive/Refractory: Liver transplantation for patients with failed Kasai procedure or those presenting late with established cirrhosis.

Complications

  • Progressive biliary cirrhosis.
  • Portal HTN (leading to esophageal varices, ascites).
  • Recurrent ascending cholangitis (post-Kasai).
  • Liver failure.